3 results
8-K
EX-99.1
BTTX
Better Therapeutics Inc
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am
, particularly racial and ethnic minority groups, and those from lower socioeconomic backgrounds. Factors like limited access to healthcare, health disparities
424B3
BTTX
Better Therapeutics Inc
13 May 22
Prospectus supplement
8:44am
draws. -0.27% -0.3 BT-001 Trial population represented racial, ethnic, geographic and socioeconomic diversity. -0.4 -0.38% Participants had long
8-K
EX-99.2
BTTX
Better Therapeutics Inc
13 May 22
Better Therapeutics Reports First Quarter 2022 Financial Results and Provides
7:27am
represented racial, ethnic, geographic and socioeconomic diversity. -0.4 -0.38% Participants had long-standing type 2 diabetes, BT-001 high
- Prev
- 1
- Next